1. Oral Bisacodyl Is Effective and Well-Tolerated in Patients With Chronic Constipation 
Michael A. Kamm, Stefan Mueller–Lissner, Arnold Wald, Erika Richter, Ros Swallow, Ulrika Gessner 
Clinical Gastroenterology and Hepatology 
Volume 9, Issue 7, Pages (July 2011)
DOI: /j.cgh
Copyright © 2011 AGA Institute Terms and Conditions

2. Figure 1
Disposition of participants (treated set). *Some patients fulfilled more than 1 protocol violation.
Clinical Gastroenterology and Hepatology 2011 9, DOI: ( /j.cgh )
Copyright © 2011 AGA Institute Terms and Conditions

3. Figure 2
Adjusted mean number of (A) CSBMs per week over the 4-week treatment period and (B) CSBMs and SBMs per week during treatment with bisacodyl 10 mg once daily or placebo (full analysis set; FAS). *P < .0001; analysis of covariance (ANCOVA).
Clinical Gastroenterology and Hepatology 2011 9, DOI: ( /j.cgh )
Copyright © 2011 AGA Institute Terms and Conditions

4. Figure 3
Adjusted mean improvement from baseline in the PAC-QOL scores (analysis of covariance [ANCOVA]; P < with exception of psychosocial discomfort, P = .0070; FAS).
Clinical Gastroenterology and Hepatology 2011 9, DOI: ( /j.cgh )
Copyright © 2011 AGA Institute Terms and Conditions